Chemours is trading 4.5% up at $15.47 as U.S. equities move higher.

  • Nasdaq Composite is up 0.78% and the S&P 500 is up 0.35%.
  • No verified company-specific announcement for August 12, 2026 has emerged; the move appears to be a broad-market rebound after Chemours’ second-quarter earnings miss and UBS’s August 10 downgrade tied to refrigerants weakness.
  • Trading is active during the early regular session, but no volume figure was provided. Confidence is low because the company-specific catalyst remains unconfirmed.